McKesson Corporation (BMV:MCK)

Market Cap	1.82T
Revenue (ttm)	7.10T
Net Income (ttm)	73.97B
Shares Out	n/a
EPS (ttm)	589.13
PE Ratio	24.64
Forward PE	20.11
Dividend	58.63 (0.40%)
Ex-Dividend Date	Dec 1, 2025

Volume	40
Average Volume	168
Open	14,545
Previous Close	15,650
Day's Range	14,545 - 14,545
52-Week Range	12,403 - 15,725
Beta	0.38
RSI	63.42
Earnings Date	Feb 4, 2026

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: MCK

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD